Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Emma Schiller"'
Autor:
Christoph U. Correll, Amber Martin, Charmi Patel, Carmela Benson, Rebecca Goulding, Jennifer Kern-Sliwa, Kruti Joshi, Emma Schiller, Edward Kim
Publikováno v:
npj Schizophrenia, Vol 8, Iss 1, Pp 1-10 (2022)
Abstract Clinical practice guidelines (CPGs) translate evidence into recommendations to improve patient care and outcomes. To provide an overview of schizophrenia CPGs, we conducted a systematic literature review of English-language CPGs and synthesi
Externí odkaz:
https://doaj.org/article/f378dd198d984b11ab3a7782b1dff956
Autor:
Farrukh Shah, Krystal Huey, Sohan Deshpande, Monica Turner, Madhura Chitnis, Emma Schiller, Aylin Yucel, Luciana Moro Bueno, Esther Natalie Oliva
Publikováno v:
Journal of Clinical Medicine; Volume 11; Issue 15; Pages: 4448
Among the difficulties of living with β-thalassemia, patients frequently require blood transfusions and experience iron overload. As serum ferritin (SF) provides an indication of potential iron overload, we conducted a systematic literature review (
Autor:
Esther Natalie Oliva, Krystal Huey, Sohan Deshpande, Monica Turner, Madhura Chitnis, Emma Schiller, Derek Tang, Aylin Yucel, Christina Hughes, Farrukh Shah
Publikováno v:
Journal of Clinical Medicine, Vol 11, Iss 895, p 895 (2022)
Journal of Clinical Medicine; Volume 11; Issue 3; Pages: 895
Journal of Clinical Medicine; Volume 11; Issue 3; Pages: 895
Anemia is the most common form of cytopenia in patients with myelodysplastic syndromes (MDS), who require chronic red blood cell transfusions and may present high serum ferritin (SF) levels as a result of iron overload. To better understand the poten
Publikováno v:
Open Forum Infectious Diseases
Background In 2016, the World Health Organization estimated the global incidence of gonorrhea (GC) to be 86.9 million, and the reported incidence of GC in 2017 was 145.8 cases per 100,000 females and 212.8 cases per 100,000 males in the US. GC theref
Publikováno v:
Journal of Clinical Oncology. 39:e17571-e17571
e17571 Background: Women diagnosed with advanced or recurrent endometrial cancer (EC) have a poor prognosis, with a 5-year survival of only 15% to 17%. While a multi-modality approach is often used for newly diagnosed EC including platinum-based chem